• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Digital Pathology

Q/A: Proscia Co-Founder Talks Impact of DICOM in Digital Pathology

by Fred Pennic 11/07/2024 Leave a Comment

Q/A: Proscia Co-Founder Talks Impact of DICOM in Digital Pathology

The world of digital pathology is undergoing a significant transformation, with the adoption of DICOM (Digital Imaging and Communications in Medicine) emerging as a game-changer. This international standard, already widely used in radiology, is poised to transform how pathology images and data are stored, shared, and analyzed. By promoting interoperability among various hardware and software solutions, DICOM empowers laboratories to build more efficient and scalable digital pathology
Read More

Aignostics Secures $34M to Advance AI-Powered Pathology and Precision Medicine

by Fred Pennic 10/29/2024 Leave a Comment

Aignostics Secures $34M to Advance AI-Powered Pathology and Precision Medicine

What You Should Know:  - Aignostics, a leading AI company specializing in pathology data analysis, raised $34M in Series B funding, led by ATHOS with participation from Mayo Clinic and growth financing from HTGF, alongisde existing investors Wellington Partners, Boehringer Ingelheim Venture Fund, CARMA Fund, and VC Fonds Technologie managed by IBB Ventures.  - Aignostics combines proprietary access to multimodal clinical data with cutting-edge AI technology and rigorous
Read More

Bioptimus and Proscia Accelerate AI Development in Pathology with H-optimus-0 Integration

by Fred Pennic 10/23/2024 Leave a Comment

FDA Clears Proscia's AI-Powered Digital Pathology Solution for Cancer Diagnosis

What You Should Know:  - Bioptimus, a French startup developing cutting-edge AI foundation models for biology, has announced a strategic partnership with Proscia, a provider of AI-enabled pathology solutions.  - The collaboration integrates Bioptimus' H-optimus-0 foundation model into Proscia's Concentriq® Embeddings, empowering researchers and data scientists to achieve breakthroughs in AI development at an unprecedented pace. Unlocking the Power of Foundation
Read More

Accelerating Drug Discovery: Proscia Launches Concentriq Embeddings and AI Toolkit

by Fred Pennic 10/03/2024 Leave a Comment

Accelerating Drug Discovery: Proscia Launches Concentriq Embeddings and AI Toolkit

What You Should Know:  - Proscia, a provider of AI-powered pathology solutions, is accelerating the pace of drug discovery and diagnostic development with the launch of Concentriq® Embeddings and the Proscia AI Toolkit.  - These powerful new tools empower life sciences organizations to leverage the full potential of artificial intelligence in pathology, leading to faster breakthroughs and improved patient outcomes. Transforming AI Development in Pathology Integrated into
Read More

PathPresenter Raises $7.5M to Accelerate Digital Pathology Workflows

by Syed Hamza Sohail 09/12/2024 Leave a Comment

PathPresenter Raises $7.5M to Accelerate Digital Pathology Workflows

What You Should Know: -  PathPresenter, the global image sharing platform for pathology, announced today that it has closed a Series A funding round of $7.5 million to accelerate the adoption of the company’s enterprise pathology workflow solution. - The funding was led by AVANT BIO, with participation from Barco NV and Modi Ventures. The funds will be used to advance the features and interoperability of the vendor-agnostic platform, invest in talent across engineering and commercial
Read More

Fimlab to Deploy Proscia’s AI-Enabled Digital Pathology Platform

by Fred Pennic 09/09/2024 Leave a Comment

Fimlab Partners with Proscia to Advance AI-Enabled Digital Pathology

What You Should Know:  - Fimlab Laboratories, a provider of laboratory services, research, and training, has announced a partnership with Proscia, a global leader in AI-enabled pathology solutions.  - This collaboration will leverage Proscia's software platform to enhance Fimlab's digital pathology capabilities and drive more precise results. The Benefits of Digital Pathology Digital pathology is transforming the way pathologists analyze tissue samples. By transitioning to
Read More

Paige Unveils AI Co-Pilot for Pathology & Oncology, Paige Alba

by Fred Pennic 09/05/2024 Leave a Comment

What You Should Know:  - Paige, a provider of next-generation artificial intelligence has introduced Paige Alba, a groundbreaking clinical-grade multimodal co-pilot designed to transform personalized medicine and precision oncology.  - Leveraging the power of Paige's Foundation Models, Alba delivers real-time AI-driven patient insights, marking a significant step towards Artificial General Intelligence (AGI). A Cohesive Solution for Personalized Medicine Paige Alba
Read More

PathAI’s AISight Dx Receives CE Mark for Primary Diagnosis

by Fred Pennic 08/29/2024 Leave a Comment

PathAI Lands $60M to Accelerate AI-Powered Pathology Platform

What You Should Know:  - PathAI, a pioneer in AI-powered digital pathology, has achieved a significant milestone with the CE mark certification of its AISight Dx Image Management System (IMS) for primary diagnosis.  - The certification paves the way for PathAI's expansion into the European diagnostic pathology market, offering pathologists a powerful tool to enhance their interpretations and improve laboratory efficiency. AISight Dx: A Comprehensive Digital Pathology
Read More

PathAI Introduces AI-Based Measurement for MASH Scoring

by Fred Pennic 08/13/2024 Leave a Comment

PathAI Introduces AI-Based Measurement for MASH Scoring

What You Should Know:  - PathAI, a leader in AI-powered digital pathology solutions, announced today the launch of AIM-MASH on its AISight Image Management System (IMS).  - The new product offers advanced AI-based measurement tools to support pathologists in assessing Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) using the MASH Clinical Research Network (CRN) Activity Score. AIM-MASH Integration with AISight By integrating AIM-MASH with AISight, PathAI
Read More

Clarapath Secures $36M to Automate Pathology Labs with AI-Powered Robotics

by Fred Pennic 07/24/2024 Leave a Comment

Clarapath and Mayo Clinic Modernize Pathology Labs with Robotics, AI & Automation

What You Should Know:  - Clarapath, a leading medical robotics company raises $36M in its Series B-1 round led by Northwell Ventures with participation from strategic players like Mayo Clinic and Ochsner Ventures, bringing Clarapath's total funding to $75M. - The company is on a mission to modernize and transform pathology labs through automation and robotics. The Pathology Challenge: Backlog, Labor Shortages, and Manual Processes Pathology, the microscopic examination of
Read More

  • Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Interim pages omitted …
  • Go to page 8
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |